Literature DB >> 8285756

Inhaled nitric oxide for pulmonary hypertension after repair of exomphalos.

O I Miller1, J W Gaynor, D J Macrae, R C Tasker.   

Abstract

Inhaled nitric oxide was used successfully to treat a newborn infant with severe pulmonary hypertension complicating repair of congenital exomphalos. The infant had failed conventional treatment and extracorporeal membrane oxygenation was unsuitable because of the risk of bleeding from the recent laparotomy. Extended treatment with inhaled nitric oxide appears safe and may offer an alternative to mechanical life support in severe cases of neonatal pulmonary hypertension.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8285756      PMCID： PMC1029596          DOI： 10.1136/adc.69.5_spec_no.518

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  9 in total

1.  Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; S R Neish; E Shaffer; S H Abman
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

Review 2.  Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.

Authors:  L J Ignarro
Journal:  Circ Res       Date:  1989-07       Impact factor: 17.367

Review 3.  Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.

Authors:  S Moncada; M W Radomski; R M Palmer
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

4.  Intraoperative use of inhaled low-dose nitric oxide.

Authors:  O I Miller; J James; M J Elliott
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209

5.  Anterior abdominal wall defects.

Authors:  P M Lafferty; A J Emmerson; P J Fleming; J D Frank; H R Noblett
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

6.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J D Roberts; D M Polaner; P Lang; W M Zapol
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

7.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

8.  Pulmonary hypertensive crises following surgery for congenital heart defects in young children.

Authors:  R A Hopkins; C Bull; S G Haworth; M R de Leval; J Stark
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

9.  Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics.

Authors:  D S Celermajer; S Cullen; J E Deanfield
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690
  9 in total
  3 in total

Review 1.  Response to inhaled nitric oxide in premature and term neonates.

Authors:  T Hoehn; M F Krause
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  Changes in alveolar-arterial oxygen difference and oxygenation index during low-dose nitric oxide inhalation in 15 newborns with severe respiratory insufficiency.

Authors:  Z Stranák; V Zábrodský; J Simák
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

3.  Frequency of anomalies and hospital outcomes in infants with gastroschisis and omphalocele.

Authors:  Kristin M Corey; Christoph P Hornik; Matthew M Laughon; Kerstin McHutchison; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2014-06-11       Impact factor: 2.699
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.